direct/ CGC: New product information website concerning allergy therapy

Allergy information for Patients in six different languages at azelastine.info

MEDA Pharma, headquartered in Solna, Sweden, has established a new informational website for patients concerning allergy therapy with the active ingredient Azelastin (i.e. in Allergodil® akut).
Patients can acquire useful information about allergies -the symptoms, the different options of treatment and helpful information about Azelastin - a wide variety of interesting and helpful information is offered at www.azelastine.info.
Currently the information portal is accessible in English and German with four further language versions (French, Spanish, Italian and Swedish) to be coming soon.
Up-to-date press releases, links to websites from various organisations, associations, and patient groups round off the website. Members of the academic press can access a password-protected site with current press releases.

Azelastin Website:
http://www.azelastine.info

Screenshot
http://www.directnewsroom.de/servlets/LoadBinaryServlet/1861066/Screenshot.jpg

Meda is one of Europe´s leading specialty pharma companies, with focus on marketing and market-adapted product development. Long-term partnerships and acquisitions are fundamental factors in its strategy. Meda is represented in 24 countries and has 900 employees in marketing and sales.

983 characters (with spaces and heading)

Contact:

CGC - Cramer Gesundheits Consulting GmbH
Dr. Sibylle Bergmann-Matz
Biologist
PR Consultant
bergmann@cgc-pr.com
http://www.cgc-pr.com

The announcement distributed by directnews.
The issuer is solely responsible for the content of this announcement.

This release was published on openPR.